Hikma Addresses Advair Issues In US

Responds To All Outstanding Questions In The FDA’s CRL

 
• By David Wallace
Two_Ticks
Hikma says it has ticked off every question posed by the FDA’s Complete Response Letter • Source: Shutterstock

More from Generics

More from Products